Bayer's Latest Stage 2 Trial Could Be A Boon For Shares By: Benzinga via Benzinga August 31, 2015 at 15:14 PM EDT Bayer AG (ADR) (OTC: BAYRY) recently finished a mid-stage trial for a heart failure drug, finerenone, which showed a ... Read More >> Related Stocks: Bayer Aktienges ADR Pfizer